Zhejiang Hisun Pharmaceutical Co., Ltd. (SHA:600267)
China · Delayed Price · Currency is CNY 11.52
-0.13 (-1.12%)
Apr 28, 2026, 3:00 PM CST
SHA:600267 Market Cap
SHA:600267 has a market cap or net worth of 13.38 billion as of April 28, 2026. Its market cap has increased by 29.80% in one year.
Market Cap
13.38B
Enterprise Value
15.27B
Revenue
10.31B
Ranking
n/a
PE Ratio
19.30
Stock Price
11.52
Market Cap Chart
Since August 15, 2006, SHA:600267's market cap has increased from 2.44B to 13.38B, an increase of 449.42%. That is a compound annual growth rate of 9.03%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 27, 2026 | 13.53B | 17.62% |
| Dec 31, 2025 | 11.50B | 18.59% |
| Dec 31, 2024 | 9.70B | -12.87% |
| Dec 29, 2023 | 11.13B | -13.94% |
| Dec 30, 2022 | 12.94B | -22.69% |
| Dec 31, 2021 | 16.73B | 4.84% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Shenzhen Hepalink Pharmaceutical Group | 14.47B |
| Beijing Aosaikang Pharmaceutical | 14.13B |
| Zhejiang Medicine | 13.80B |
| Guobang Pharma | 13.39B |
| Shenzhen Chipscreen Biosciences | 13.08B |
| Tibet Rhodiola Pharmaceutical Holding Co. | 13.02B |
| Shanghai Shyndec Pharmaceutical | 12.86B |
| Ningbo Menovo Pharmaceutical | 12.44B |